Lilly (Eli) & Co. | Business Contracts

Underwriting Agreement, dated February 23, 2023, among Eli Lilly and Company and J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC and Morgan... (Filed With SEC on February 24, 2023)

Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on February 24, 2023)

Form of Performance Award under the 2002 Lilly Stock Plan (Filed With SEC on February 22, 2023)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 22, 2023)

Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 22, 2023)

Form of Non-Compete Payment Agreement (Filed With SEC on February 22, 2023)

Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on November 1, 2022)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on November 1, 2022)

Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on November 1, 2022)

Description of the Company's 0.500% Notes due 2033, 1.125% Notes due 2051, and 1.375% Notes due 2061 (Filed With SEC on February 23, 2022)

Description of the Company's 1.625% Notes due 2043 (Filed With SEC on February 23, 2022)

Form of Performance Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)

Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 23, 2022)

Form of Performance Award under the 2002 Lilly Stock Plan (non-executive officer) (Filed With SEC on February 23, 2022)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 23, 2022)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer) (Filed With SEC on February 23, 2022)

Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)

Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 23, 2022)

Form of Relative Value Award under the 2002 Lilly Stock Plan (non-executive) (Filed With SEC on February 23, 2022)

Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (Filed With SEC on February 23, 2022)

The Loxo Oncology, Inc. Bonus Plan (Filed With SEC on February 23, 2022)

Underwriting Agreement, dated September 8, 2021, among Eli Lilly and Company and Merrill Lynch International, Barclays Bank PLC, BNP Paribas, Citigroup Global Markets Limited and... (Filed With SEC on September 10, 2021)

Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on September 10, 2021)

Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on April 30, 2021)

Release Agreement, effective as of February 9, 2021, by and between Eli Lilly and Company and Joshua L. Smiley (Filed With SEC on April 30, 2021)

Form of Performance Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)

Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 17, 2021)

Form of Performance Award under the 2002 Lilly Stock Plan (non-executive officer) (Filed With SEC on February 17, 2021)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 17, 2021)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer) (Filed With SEC on February 17, 2021)

Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)

Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete) (Filed With SEC on February 17, 2021)

Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (Filed With SEC on February 17, 2021)

The Eli Lilly and Company Bonus Plan, as amended (Filed With SEC on February 17, 2021)

2007 Change in Control Severance Pay Plan for Select Employees, as amended (Filed With SEC on February 17, 2021)

Underwriting Agreement, dated August 20, 2020, among the Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley &... (Filed With SEC on August 21, 2020)

Form of Officers Certificate setting forth the terms and form of the 2060 Notes and certain matters with respect to the New 2050 Notes (Filed With SEC on August 21, 2020)

Underwriting Agreement (Filed With SEC on April 28, 2020)

Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on April 28, 2020)

Description of the Company's Common Stock (Filed With SEC on February 19, 2020)

Description of the Company's 1.000% EUR Notes due 2022, 1.625% EUR Notes due 2026, and 2.125% EUR Notes due 2030 (Filed With SEC on February 19, 2020)

Description of the Company's 6.77% Notes due 2036 (Filed With SEC on February 19, 2020)

Description of the Company's 7 1/8% Notes due 2025 (Filed With SEC on February 19, 2020)

Description of the Company's 0.625% EUR Notes due 2031 and 1.700% EUR Notes due 2049 (Filed With SEC on February 19, 2020)

Form of Performance Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)

Form of Relative Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)

Restricted Stock Unit Award to Michael Harrington under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2020)

Underwriting Agreement (Filed With SEC on November 6, 2019)

Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on November 6, 2019)

Underwriting Agreement (Filed With SEC on February 21, 2019)

Form of Officers Certificate setting forth the terms and form of the Notes (Filed With SEC on February 21, 2019)

Form of Performance Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2019)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 19, 2019)

2002 Lilly Stock Plan, as amended (Filed With SEC on July 25, 2018)

Form of Performance Award under the 2002 Lilly Stock Plan (Filed With SEC on February 20, 2018)

Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Filed With SEC on February 20, 2018)

Underwriting Agreement (Filed With SEC on May 5, 2017)

ELI LILLY AND COMPANY Officers Certificate Pursuant to Section 3.01 of the Indenture May [__], 2017 (Filed With SEC on May 5, 2017)

Eli Lilly and Company Performance Award (for Executive Officers) (Filed With SEC on February 21, 2017)

Eli Lilly and Company Shareholder Value Award (for Executive Officers) (Filed With SEC on February 21, 2017)

Eli Lilly and Company Shareholder Value Award (for Executive Officers) (Filed With SEC on February 19, 2016)

Underwriting Agreement (Filed With SEC on May 29, 2015)

Eli Lilly And Company Officers Certificate Pursuant to Section 3.01 of the Indenture June 2, 2015 (Filed With SEC on May 29, 2015)

Underwriting Agreement (Filed With SEC on February 26, 2015)

Eli Lilly And Company Officers Certificate Pursuant to Section 3.01 of the Indenture March [ ], 2015 (Filed With SEC on February 26, 2015)

FIRST AMENDMENT TO STOCK AND ASSET PURCHASE AGREEMENT (Filed With SEC on February 19, 2015)

Eli Lilly and Company Performance Award (for Executive Officers) (Filed With SEC on February 19, 2015)

Eli Lilly and Company Shareholder Value Award (for Executive Officers) (Filed With SEC on February 19, 2015)

Underwriting Agreement (Filed With SEC on February 24, 2014)

Eli Lilly And Company Officers Certificate Pursuant to Section 3.01 of the Indenture February [ ], 2014 (Filed With SEC on February 24, 2014)

ELI LILLY AND COMPANY THE LILLY DEFERRED COMPENSATION PLAN (as Amended and Restated Effective 1/1/2009) (Filed With SEC on February 19, 2014)

The Eli Lilly and Company Bonus Plan (as amended effective January 1, 2014) (Filed With SEC on February 19, 2014)

The Eli Lilly and Company Bonus Plan (as amended effectiveJanuary 1, 2011) TABLE OF CONTENTS (Filed With SEC on February 22, 2011)

Eli Lilly and Company Performance Award (for Executive Officers) (Filed With SEC on February 22, 2010)

Eli Lilly and Company Restricted Stock Unit (for Executive Officers) (Filed With SEC on February 22, 2010)

Eli Lilly and Company Shareholder Value Award (Filed With SEC on February 22, 2010)

The Eli Lilly and Company Bonus Plan (Filed With SEC on February 22, 2010)

Underwriting Agreement (Filed With SEC on March 6, 2009)

TRIPARTITE AGREEMENT (Filed With SEC on February 27, 2009)

The Eli Lilly and Company Bonus Plan (as amended January 1, 2009) (Filed With SEC on February 27, 2009)

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA UNITED STATES OF AMERICA : v. : CRIMINAL NO. ELI LILLY AND COMPANY : (Filed With SEC on February 27, 2009)

SETTLEMENT AGREEMENT (Filed With SEC on February 27, 2009)

CORPORATE INTEGRITY AGREEMENT between the Office of Inspector General of the Department of Health and Human Services and Eli Lilly and Company (Filed With SEC on February 27, 2009)

Regulation FD Disclosure (Filed With SEC on December 11, 2008)

2002 LILLY STOCK PLAN As amended effective January 1, 2009 (Filed With SEC on November 3, 2008)

ELI LILLY AND COMPANY (Filed With SEC on November 3, 2008)

the Purchaser will commence a tender offer (the Offer) to acquire all of the outstanding shares of common stock, par value $0.001, of ImClone, and the associated preferred stock... (Filed With SEC on October 10, 2008)

No Payout Level 1 Level 2 Level 3 Level 4 Level 5 Level 6 Stock Price $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] % of Target 0 % 40 % 60 % 80 % 100 % 120 % 140 % (Filed With SEC on May 3, 2007)

Underwriting Agreement (Filed With SEC on March 14, 2007)

Form of 5.20% Note due 2017 (Filed With SEC on March 14, 2007)

Form of 5.50% Note due 2027 (Filed With SEC on March 14, 2007)

Form of 5.55% Note due 2037 (Filed With SEC on March 14, 2007)

1994 LILLY STOCK PLAN, as amended through April 15, 2002 (Filed With SEC on February 28, 2007)

1998 LILLY STOCK PLAN As amended and restated effective October 15, 2001 (Filed With SEC on February 28, 2007)

The Eli Lilly and Company Bonus Plan (Filed With SEC on November 3, 2006)

ELI LILLY AND COMPANY (Filed With SEC on November 3, 2006)

Bonus Plan, as amended (Filed With SEC on March 1, 2006)

Summary of 2006 Compensation for Non-Employee Directors (Filed With SEC on March 1, 2006)

Summary of 2006 Compensation for Named Executive Officers (Filed With SEC on March 1, 2006)

The Eli Lilly and Company Bonus Plan, as Amended (Filed With SEC on November 3, 2005)

Master Settlement Agreement (Filed With SEC on November 3, 2005)

ELI LILLY SERVICES, INC. as Issuer and ELI LILLY AND COMPANY as Guarantor and CITIBANK, N.A. as Trustee (Filed With SEC on August 10, 2005)

Eli Lilly Services, Inc. Eli Lilly and Company Officers Certificate Pursuant to Section 3.01 of the Indenture (Filed With SEC on August 10, 2005)

Summary of 2005 Compensation for Non-Employee Directors (Filed With SEC on March 8, 2005)

Summary of 2005 Compensation for Named Executive Officers (Filed With SEC on March 8, 2005)

Letter concerning Retirement Benefits for Charles E. Golden (Filed With SEC on March 8, 2005)

Letter concerning Retirement Benefits For Steven M. Paul (Filed With SEC on March 8, 2005)

Arrangement Regarding Retirement Benefits (Filed With SEC on March 8, 2005)

Time Sharing Agreement (Filed With SEC on March 8, 2005)

Deferred Compensation Plan (Filed With SEC on August 5, 2004)

Change in Control Severance Pay Plan (Filed With SEC on August 5, 2004)

2007 Change in Control Severance Pay Plan (Filed With SEC on August 5, 2004)

Rights Agreement (Filed With SEC on March 15, 2004)

The Lilly Deferred Compensation Plan (Filed With SEC on March 15, 2004)

The Lilly Directors' Deferral Plan (Filed With SEC on March 15, 2004)

GlobalShares Stock Plan, as amended (Filed With SEC on March 20, 2003)

Form of 2.90 Percent Note Due 2008 (Filed With SEC on March 17, 2003)

Form of 4.50 Percent Note Due 2018 (Filed With SEC on March 17, 2003)

Lilly (Eli) & Co. (125)